Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths
Dai Y, Wang Q, Gonzalez Lopez A, Anders M, Malfertheiner P, Vieth M, Kemmner W (2018)
Publication Type: Journal article
Publication year: 2018
Journal
Book Volume: 11
Pages Range: 116-124
Journal Issue: 1
DOI: 10.1016/j.tranon.2017.10.003
Abstract
BACKGROUND: Barrett's esophagus metaplasia is the key precursor lesion of esophageal adenocarcinoma. The aim of this study was to find a subset of markers that may allow the identification of patients at risk for esophageal adenocarcinoma, and to determine genes differentially expressed in esophageal squamous cell carcinoma. METHODS: Laser capture microdissection technique was applied to procure cells from defined regions. Genome-wide RNA profiling was performed on esophageal adenocarcinoma (n = 21), Barrett's esophagus (n = 20), esophageal squamous carcinoma (n = 9) and healthy esophageal biopsies (n = 18) using the Affymetrix Human Genome U133plus 2.0 array. Microarray results were validated by quantitative real-time polymerase chain reaction in a second and independent cohort and by immunohistochemistry of two putative markers in a third independent cohort. RESULTS: Through unsupervised hierarchical clustering and principal component analysis, samples were separated into four distinct groups that match perfectly with histology. Many genes down-regulated in esophageal cancers belong to the epidermal differentiation complex or the related GO-group “cornified envelope” of terminally differentiated keratinocytes. Similarly, retinol metabolism was strongly down-regulated. Genes showing strong overexpression in esophageal carcinomas belong to the GO groups extracellular region /matrix such as MMP1, CTHRC1, and INHBA. According to an analysis of genes strongly up-regulated in both esophageal adenocarcinoma and Barrett's esophagus, REG4 might be of particular interest as an early marker for esophageal adenocarcinoma. CONCLUSIONS: Our study provides high quality data, which could serve for identification of potential biomarkers of Barrett's esophagus at risk of esophageal adenocarcinoma progression.
Involved external institutions
Klinikum Bayreuth
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Vivantes Klinikum Berlin Spandau
Germany (DE)
Otto-von-Guericke-Universität Magdeburg
Germany (DE)
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Vivantes Klinikum Berlin Spandau
Germany (DE)
Otto-von-Guericke-Universität Magdeburg
Germany (DE)
How to cite
APA:
Dai, Y., Wang, Q., Gonzalez Lopez, A., Anders, M., Malfertheiner, P., Vieth, M., & Kemmner, W. (2018). Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths. Translational Oncology, 11(1), 116-124. https://doi.org/10.1016/j.tranon.2017.10.003
MLA:
Dai, Yiyang, et al. "Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths." Translational Oncology 11.1 (2018): 116-124.
BibTeX: Download